{
    "timestamp": "8/28/2023 9:48:01",
    "title": "Medical Product Industry Ties to Patient Advocacy Organizations\u2019 Executive Leadership",
    "link_to_resource": "https://doi.org/10.1001/jamainternmed.2023.2842",
    "creators": [
        "Shamik Bhat",
        "Joseph S. Ross",
        "Reshma Ramachandran"
    ],
    "material_type": [
        "Reading"
    ],
    "education_level": [
        "College / Upper Division (Undergraduates)",
        "Graduate / Professional",
        "Career /Technical",
        "Adult Education"
    ],
    "abstract": "Patient advocacy organizations (PAOs) advance patient interests through promotion of disease awareness, engagement with policymakers, and partnership with medical product manufacturers in research and development.1 However, there are concerns that, in addition to industry financial support\u2014which nearly half of PAOs accept2\u2014having individuals formerly or currently based in industry serve on PAOs\u2019 boards of directors and as senior leadership may influence PAOs\u2019 priorities, advocacy, and recommendations.3 We identified the 50 highest-revenue US-based PAOs and examined whether their senior leadership had been or were currently employed by the pharmaceutical and medical device industries.",
    "language": [
        "English"
    ],
    "conditions_of_use": "I don't see any of these",
    "primary_user": [
        "Teacher",
        "Administrator",
        "Librarian",
        "Journal Editors"
    ],
    "subject_areas": [
        "Life Science",
        "Physical Science",
        "Social Science"
    ],
    "FORRT_clusters": [
        "Academic Life and Culture"
    ],
    "tags": [
        "Transparency",
        "Conflicts of Interest",
        "Patient Advocacy Organizations",
        "Industry"
    ]
}